StockData
Adlai Nortye Group Ltd. logo

Adlai Nortye Group Ltd. (ANL) stock

ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 10, 2026Score 0/30
$8.74−0.74 (-7.81%)

Close on Nov 18, 2026Market cap $349.60MP/E –Yield –

Adlai Nortye operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$35.70M. The highest annual figure on record is -$8.65M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$35.70M–
FY2024Dec 31, 2024-$52.93M–
FY2023Dec 31, 2023-$72.55M–
FY2022Dec 31, 2022-$67.27M–
FY2021Dec 31, 2021-$8.65M–

More Adlai Nortye figures

See a number that looks wrong?